Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Similar Items

• Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
  od: Adsit, Sandra, i dr.
  Izdano: (2017)
• Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
  od: Menter, Alan, i dr.
  Izdano: (2016)
• Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
  od: Pariser, David, i dr.
  Izdano: (2017)
• Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies
  od: Kircik, Leon, i dr.
  Izdano: (2016)
• Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
  od: Alessio Gambardella
  Izdano: (2019-09-01)